Recombinant multi-species CAMP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CAMP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of an antimicrobial peptide family, characterized by a highly conserved N-terminal signal peptide containing a cathelin domain and a structurally variable cationic antimicrobial peptide, which is produced by extracellular proteolysis from the C-terminus. The protein plays an important role in innate immunity defense against viruses. In addition to its antibacterial, antifungal, and antiviral activities, the encoded protein functions in cell chemotaxis, immune mediator induction, and inflammatory response regulation. [provided by RefSeq, Sep 2021]
The Alternative Names of target: 18 kDa cationic antimicrobial protein (CAP-18,CAMP,CAP-18,CAP18,CLP,CRAMP,Camp,Cathelicidin antimicrobial peptide,Cnlp,Cramp,FALL-39,FALL39,HSD26,LL37,MCLP,hCAP-18)
Go
to CAMP products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T34318-Ag-1/ GM-Tg-hg-T34318-Ag-2 | Human CAMP protein | Human |
| GM-Tg-rg-T34318-Ag-1/ GM-Tg-rg-T34318-Ag-2 | Rat CAMP protein | Rat |
| GM-Tg-mg-T34318-Ag-1/ GM-Tg-mg-T34318-Ag-2 | Mouse CAMP protein | Mouse |
| GM-Tg-cynog-T34318-Ag-1/ GM-Tg-cynog-T34318-Ag-2 | Cynomolgus/Rhesus macaque CAMP protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T34318-Ag-1/ GM-Tg-felg-T34318-Ag-2 | Feline CAMP protein | Feline |
| GM-Tg-cang-T34318-Ag-1/ GM-Tg-cang-T34318-Ag-2 | Canine CAMP protein | Canine |
| GM-Tg-bovg-T34318-Ag-1/ GM-Tg-bovg-T34318-Ag-2 | Bovine CAMP protein | Bovine |
| GM-Tg-equg-T34318-Ag-1/ GM-Tg-equg-T34318-Ag-2 | Equine CAMP protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T34318-Ag-1/ GM-Tg-hg-T34318-Ag-2;
GM-Tg-rg-T34318-Ag-1/ GM-Tg-rg-T34318-Ag-2;
GM-Tg-mg-T34318-Ag-1/ GM-Tg-mg-T34318-Ag-2; GM-Tg-cynog-T34318-Ag-1/ GM-Tg-cynog-T34318-Ag-2; GM-Tg-felg-T34318-Ag-1/ GM-Tg-felg-T34318-Ag-2; GM-Tg-cang-T34318-Ag-1/ GM-Tg-cang-T34318-Ag-2; GM-Tg-bovg-T34318-Ag-1/ GM-Tg-bovg-T34318-Ag-2; GM-Tg-equg-T34318-Ag-1/ GM-Tg-equg-T34318-Ag-2 |
| Products Name | CAMP protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CAMP |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CAMP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.